Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


21.01.2019

2 Biochem Biophys Res Commun
5 BMC Cancer
3 Cancer Res
2 Eur Radiol
1 Gastroenterology
1 Hepatology
1 J Gastroenterol
1 J Gastroenterol Hepatol
6 J Hepatol
1 Lancet
2 Lancet Gastroenterol Hepatol
2 Oncogene
7 PLoS One
1 Transplant Proc


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHAO Z, Zhong L, He K, Qiu C, et al
    Cholesterol attenuated the progression of DEN-induced hepatocellular carcinoma via inhibiting SCAP mediated fatty acid de novo synthesis.
    Biochem Biophys Res Commun. 2019 Jan 10. pii: S0006-291X(18)32868.
    PubMed     Text format     Abstract available

  2. HUANG F, Wen C, Zhuansun Y, Huang L, et al
    A novel long noncoding RNA OECC promotes colorectal cancer development and is negatively regulated by miR-143-3p.
    Biochem Biophys Res Commun. 2018;503:2949-2955.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. SONG X, Guo C, Zheng Y, Wang Y, et al
    Post-transcriptional regulation of cancer/testis antigen MAGEC2 expression by TRIM28 in tumor cells.
    BMC Cancer. 2018;18:971.
    PubMed     Text format     Abstract available

  4. ZHENG J, Jia L, Mori S, Kodama T, et al
    Evaluation of metastatic niches in distant organs after surgical removal of tumor-bearing lymph nodes.
    BMC Cancer. 2018;18:608.
    PubMed     Text format     Abstract available

  5. SAHIN IH, Elias H, Chou JF, Capanu M, et al
    Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.
    BMC Cancer. 2018;18:769.
    PubMed     Text format     Abstract available

  6. CHIU KWH, Lam KO, An H, Cheung GTC, et al
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
    BMC Cancer. 2018;18:776.
    PubMed     Text format     Abstract available

  7. MAK D, Sengayi M, Chen WC, Babb de Villiers C, et al
    Liver cancer mortality trends in South Africa: 1999-2015.
    BMC Cancer. 2018;18:798.
    PubMed     Text format     Abstract available


    Cancer Res

  8. KOHLI S, Bhardwaj A, Kumari R, Das S, et al
    SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Cancer Res. 2018;78:645-658.
    PubMed     Text format     Abstract available

  9. VERZELLA D, Bennett J, Fischietti M, Thotakura AK, et al
    GADD45beta Loss Ablates Innate Immunosuppression in Cancer.
    Cancer Res. 2018;78:1275-1292.
    PubMed     Text format     Abstract available

  10. SAKAI E, Nakayama M, Oshima H, Kouyama Y, et al
    Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
    Cancer Res. 2018;78:1334-1346.
    PubMed     Text format     Abstract available


    Eur Radiol

  11. BONATTI M, Valletta R, Zamboni GA, Lombardo F, et al
    Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5932.
    PubMed     Text format     Abstract available

  12. LEE DH, Lee JM, Yu MH, Hur BY, et al
    Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
    Eur Radiol. 2019 Jan 14. pii: 10.1007/s00330-018-5941.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. CHATURANTABUT S, Shwartz A, Evason KJ, Cox AG, et al
    Estrogen Activation of G protein-coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30031.
    PubMed     Text format     Abstract available


    Hepatology

  14. CHEN H, Gao F, He M, Ding XF, et al
    Long-read RNA Sequencing identifies Novel Splice Variants in Hepatocellular Carcinoma and Tumor-specific Isoforms.
    Hepatology. 2019 Jan 13. doi: 10.1002/hep.30500.
    PubMed     Text format     Abstract available


    J Gastroenterol

  15. BRAR G, Tsukamoto H
    Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science.
    J Gastroenterol. 2019 Jan 14. pii: 10.1007/s00535-018-01542.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  16. SUNG J
    Renaissance in gastroenterology and hepatology.
    J Gastroenterol Hepatol. 2019;34:5-6.
    PubMed     Text format    


    J Hepatol

  17. FORMENTIN C, De Rui M, Zoncape M, Ceccato S, et al
    The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability.
    J Hepatol. 2019 Jan 8. pii: S0168-8278(19)30005.
    PubMed     Text format     Abstract available

  18. ARROYO V, Moreau R
    Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis.
    J Hepatol. 2016 Dec 15. pii: S0168-8278(16)30577.
    PubMed     Text format    

  19. HSU YC, Yip TC, Ho HJ, Wong VW, et al
    Corrigendum to "Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B" [J Hepatol 69 (2018) 278-285].
    J Hepatol. 2019 Jan 8. pii: S0168-8278(18)32629.
    PubMed     Text format    

  20. HSU YC, Yip TC, Wong GL, Wu CY, et al
    Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues".
    J Hepatol. 2019 Jan 8. pii: S0168-8278(18)32583.
    PubMed     Text format    

  21. TSAI JF, Perng DS
    Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues.
    J Hepatol. 2019 Jan 7. pii: S0168-8278(18)32546.
    PubMed     Text format    

  22. TISCHENDORF M, Fuchs A, Zeuzem S, Lange CM, et al
    Use of prothrombin complex concentrates in patients with decompensated liver cirrhosis is associated with thromboembolic events.
    J Hepatol. 2019 Jan 7. pii: S0168-8278(18)32570.
    PubMed     Text format    


    Lancet

  23. BRAILLON A
    Laennec's cirrhosis.
    Lancet. 2019;393:131-132.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  24. COOKE GS, Andrieux-Meyer I, Applegate TL, Atun R, et al
    Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
    Lancet Gastroenterol Hepatol. 2019;4:135-184.
    PubMed     Text format     Abstract available


  25. Correction to Lancet Gastroenterol Hepatol 2018; 3: 825-36.
    Lancet Gastroenterol Hepatol. 2019;4:e1.
    PubMed     Text format    


    Oncogene

  26. ZHAO X, Reebye V, Hitchen P, Fan J, et al
    Mechanisms involved in the activation of C/EBPalpha by small activating RNA in hepatocellular carcinoma.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0665.
    PubMed     Text format     Abstract available

  27. HUANG JF, Jiang HY, Cai H, Liu Y, et al
    Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0643.
    PubMed     Text format     Abstract available


    PLoS One

  28. UCHINO K, Tateishi R, Nakagomi R, Fujiwara N, et al
    Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    PLoS One. 2018;13:e0200943.
    PubMed     Text format     Abstract available

  29. RINGE KI, von Falck C, Raatschen HJ, Wacker F, et al
    Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols.
    PLoS One. 2018;13:e0200887.
    PubMed     Text format     Abstract available

  30. LIMA JG, Nobrega LHC, Lima NN, Dos Santos MCF, et al
    Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
    PLoS One. 2018;13:e0199052.
    PubMed     Text format     Abstract available

  31. WANG X, Kwak KJ, Yang Z, Zhang A, et al
    Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    PLoS One. 2018;13:e0198552.
    PubMed     Text format     Abstract available

  32. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    PubMed     Text format     Abstract available

  33. NA SK, Choi GH, Lee HC, Shin YM, et al
    The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    PLoS One. 2018;13:e0198138.
    PubMed     Text format     Abstract available

  34. FRANCH-NADAL J, Caballeria L, Mata-Cases M, Mauricio D, et al
    Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    PLoS One. 2018;13:e0198327.
    PubMed     Text format     Abstract available


    Transplant Proc

  35. UENO T, Wada M, Hoshino K, Matsuura T, et al
    Three-Year Prospective Follow-up of Potential Pediatric Candidate for Intestinal Transplantation.
    Transplant Proc. 2018;50:2779-2782.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: